Home > Boards > US OTC > Medical - Equipment > Advanced Healthcare Technologies Inc. (AVHC)

Advanced Healthcare Technologies, Inc. Announces the Acquisition of

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
jmhollen Member Profile
 
Followed By 58
Posts 9,964
Boards Moderated 0
Alias Born 08/20/00
160x600 placeholder
jmhollen   Friday, 09/19/03 02:33:49 PM
Re: None
Post # of 161 
Advanced Healthcare Technologies, Inc. Announces the Acquisition of an Exclusive License to Market Hyper-O2/p

OMAHA, Neb.--(BUSINESS WIRE)--Sept. 19, 2003--Advanced Healthcare Technologies, Inc. (OTCBB:AVHC) today announces execution of an Exclusive Licensing Agreement with FSI Nutrition of Omaha, Nebraska, to market a proprietary amino acid Hyper-O2/p for tissue regeneration and improved wound healing.


Randall Sulhoff, President of Advanced Healthcare, stated that Hyper-O2/p is a proprietary product developed by FSI Nutrition, a leader in the sports nutrition supplement business and the developers of effervescent creatine and effervescent tyrosine. "We are very interested in any products and processes which complement our oxygen therapy products and will continue to add additional products in health and well being."

Hyper-O2/p

Hyper-O2/p is a nutraceutical food developed by FSI Nutrition exclusively for Advanced Healthcare Technologies, Inc. (OTCBB:AVHC). Prior to this product the only way to administer these nutrients was intravenously. This good tasting drink has been shown in medical research to supplement tissue rejuvenation in hospital studies which required an injection. Mr. Sulhoff stated, "We believe a regimen of Hyper-O2/p in conjunction with the hyperbaric chamber will accelerate tissue restoration."

Proprietary manufacturing processes and patent-pending technology were used to solve this dosing problem. Hospitals, prior to this development, had to mix this material in IV bags or by direct injection. Now a patient can mix up this drink themselves and drink prior to treatment. This material is designed to increase amino acid levels in proportion to your body's needs, pre and post treatment. This amino acid product is a potent protein synthesis effector. Protein synthesis is critical in muscle and tissue regeneration. This formula has been shown to increase amino acid delivery to tissues by 650%, when digested prior to therapy.

About Advanced Healthcare Technologies

Advanced Healthcare Technologies, Inc. (OTCBB:AVHC) is a company that engages in the development and incubation of companies with products and services in the healthcare industry.

For further information, visit the Advanced Healthcare Technologies, Inc. website at www.advancedhealthcaretechnologies.com (currently being updated) and visit the Advanced Hyperbaric Technologies website at www.advanced-hyperbaric.com.

CONTACT:
Advanced Healthcare Technologies, Inc.
Randall Sulhoff, 402-697-0945
800-327-4325
or
Elite Equity Marketing
Joseph Pettinelli, 410-321-5454
info@eliteequitymarketing.com


.......According to the Great Pumpkin, ".....You're in .....iHub....., Charlie Brown....."!!!
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences